Richard Saynor

Chief Executive Officer, Sandoz at Novartis AG

Richard Saynor

Richard Saynor

Chief Executive Officer, Sandoz at Novartis AG

Overview
Career Highlights

Sandoz, Inc.
Sandoz International GmbH

RelSci Relationships

1267

Number of Boards

1

Birthday

1967

Age

53
Relationships
View Relationship Details
RelSci Relationships are individuals Richard Saynor likely has professional access to. A relationship does not necessarily indicate a personal connection.
Shannon Klinger

Group General Counsel of Novartis at Novartis AG

Relationship likelihood: Strong

Vasant Narasimhan

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Harry Werner Kirsch

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Bertrand Bodson

Chief Digital Officer at Novartis AG

Relationship likelihood: Strong

Jeffrey P. George

Division Head, Alcon at Novartis AG

Relationship likelihood: Strong

Robert Weltevreden

Head of Novartis Business Services (Nbs) at Novartis AG

Relationship likelihood: Strong

John Tsai

Chief Medical Officer at Novartis AG

Relationship likelihood: Strong

Steffen Lang

Global Head of Novartis Technical Operations (Nto) at Novartis AG

Relationship likelihood: Strong

Marc Ceulemans

Head of Strategic Venture Capital Fund, Pharma Equities at Novartis AG

Relationship likelihood: Strong

Hans-Beat Gürtler

Former Global Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
PR Newswire
December 8, 2020
Sandoz generic injectable acetaminophen immediately available to US patients, strategically building hospital portfolio offering; - Acetaminophen injection used in patients 2 years and older to treat mild to moderate pain, moderate to severe pain in conju
PR Newswire
November 2, 2020
Sandoz ships first medicine in collaboration with Civica Rx to supply US hospitals; - Pantoprazole is the first Sandoz medicine to ship to Civica Rx to supply its member hospitals as part of a five-year agreement to reduce supply shortages
Marketline Newswire
July 28, 2020
Sandoz partners with Austria to boost antibiotics production
ENP Newswire
July 28, 2020
-Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe
Nasdaq
July 27, 2020
Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe
Trending People
Boris Johnson
Social media messages deter carers from having vaccination; Misinformation sprea... - The Daily Telegraph (London)
Alex Ferguson
Rejuvenated Red Devils ready to rumble in Liverpool; Their erratic form aside, t... - The Business Times Singapore
Thomas H. Gardner
Why AMC Entertainment Stock Finished Higher Today - Nasdaq
Alex Azar
Speed Up Vaccinations and Reduce the Red Tape - The New York Times
Jill T. Biden
Why Prince William and Kate Might Get the COVID-19 Vaccine on Camera - New York Observer
Trending People
Boris Johnson
Social media messages deter carers from having vaccination; Misinformation sprea... - The Daily Telegraph (London)
Alex Ferguson
Rejuvenated Red Devils ready to rumble in Liverpool; Their erratic form aside, t... - The Business Times Singapore
Thomas H. Gardner
Why AMC Entertainment Stock Finished Higher Today - Nasdaq
Alex Azar
Speed Up Vaccinations and Reduce the Red Tape - The New York Times
Jill T. Biden
Why Prince William and Kate Might Get the COVID-19 Vaccine on Camera - New York Observer
Paths to Richard Saynor
Potential Connections via
Relationship Science
You
Richard Saynor
Chief Executive Officer, Sandoz at Novartis AG
Career History
Chief Executive Officer
2019 - Current
Sandoz, Inc.

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Chief Executive Officer
Current
Sandoz International GmbH

Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria.

Chief Executive Officer, Sandoz
Current
Novartis AG

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Other Affiliations

Richard Saynor is affiliated with Sandoz, Inc., Sandoz International GmbH, Novartis AG, Generics [U.K.] Ltd.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard Saynor. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard Saynor's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard Saynor.